Skip to main content
FinSpry Logo
FinSpry
MYGN logo
MYGN
(NASDAQ)
Myriad Genetics, Inc.
$5.22-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Myriad Genetics (MYGN) Stock Price & Financial Analysis

Myriad Genetics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.39 - $4.71
52-Week High$8.59
52-Week Low$3.53
Open$4.41
Volume1.27M
Average Volume (3M)1.69M
Market Cap489.11M
Shares Outstanding93.70M
Price to Sales (P/S)0.59
Price to Book (P/B)1.45
EV/EBITDA-1.72
Revenue (TTM)829.00M
Net Income (TTM)-399.90M
Free Cash Flow (TTM)-20.80M
EPS (TTM)$-4.29
Profit Margin-48.24%
Operating Margin-8.06%
Return on Equity (ROE)-118.52%
Debt to Equity0.63
50-Day MA$4.43
200-Day MA$5.83
52-Week Change3.37%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateJul 1, 2009

Frequently Asked Questions About Myriad Genetics

What is the current stock price for MYGN?

As of the latest trading session, MYGN stock trades at $4.63. The 52-week range is $3.53–$8.59, with a day range of $4.39–$4.71.

What is the P/E ratio for MYGN?

The P/E ratio (Price-to-Earnings) for MYGN is shown in the Key Statistics section. This valuation metric helps compare Myriad Genetics, Inc. to industry peers.

Does MYGN pay dividends?

Myriad Genetics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MYGN?

Based on 6 analysts, the consensus for MYGN is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MYGN?

Myriad Genetics's market capitalization is $433.8M, classifying it as a small-cap company. Myriad Genetics operates in the Healthcare sector within the Diagnostics & Research industry.